Ferrero S - Search Results

1

Evaluation of markers of bone and collagen turnover in patients with active and preclinical Cushing's syndrome and in patients with adrenal incidentaloma.

Sartorio A, Conti A, Ferrero S, Giambona S, Re T, Passini E, Ambrosi B. Sartorio A, et al. Among authors: ferrero s. Eur J Endocrinol. 1998 Feb;138(2):146-52. doi: 10.1530/eje.0.1380146. Eur J Endocrinol. 1998. PMID: 9506857

2

Effects of 12 months rhGH treatment on bone and collagen turnover in children with constitutional growth delay.

Sartorio A, Conti A, Ferrero S, Saraifoger S, Resnik M, Baroncelli GI. Sartorio A, et al. Among authors: ferrero s. J Pediatr Endocrinol Metab. 1999 Nov-Dec;12(6):833-8. doi: 10.1515/jpem.1999.12.6.833. J Pediatr Endocrinol Metab. 1999. PMID: 10614540

3

[Effect of GH/IGF-I deficiency on bone and collagen turnover in children and adults with GH deficiency].

Sartorio A, Conti A, Monzani M, Ferrero S, Biella O, Casati G, Faglia G. Sartorio A, et al. Among authors: ferrero s. Minerva Endocrinol. 1995 Jun;20(2):135-40. Minerva Endocrinol. 1995. PMID: 8531895 Italian.

4

Modifications of biochemical markers of bone and collagen turnover during corticosteroid therapy.

Conti A, Sartorio A, Ferrero S, Ferrario S, Ambrosi B. Conti A, et al. Among authors: ferrero s. J Endocrinol Invest. 1996 Feb;19(2):127-30. doi: 10.1007/BF03349848. J Endocrinol Invest. 1996. PMID: 8778165

5

Low urinary GH levels in normal statured obese children.

Sartorio A, Conti A, Ferrero S. Sartorio A, et al. Among authors: ferrero s. Acta Paediatr. 1996 Aug;85(8):894-8. doi: 10.1111/j.1651-2227.1996.tb14178.x. Acta Paediatr. 1996. PMID: 8863865

6

Effects of chronic administration of PPAR-gamma ligand rosiglitazone in Cushing's disease.

Ambrosi B, Dall'Asta C, Cannavo S, Libe R, Vigo T, Epaminonda P, Chiodini I, Ferrero S, Trimarchi F, Arosio M, Beck-Peccoz P. Ambrosi B, et al. Among authors: ferrero s. Eur J Endocrinol. 2004 Aug;151(2):173-8. doi: 10.1530/eje.0.1510173. Eur J Endocrinol. 2004. PMID: 15296471 Clinical Trial.

7

Urinary free deoxypyridinoline levels during childhood.

Conti A, Ferrero S, Giambona S, Sartorio A. Conti A, et al. Among authors: ferrero s. J Endocrinol Invest. 1998 May;21(5):318-22. doi: 10.1007/BF03350335. J Endocrinol Invest. 1998. PMID: 9648054 Clinical Trial.

8

Long-term monitoring of rec-GH treatment by serial determination of serum aminoterminal propeptide of type III procollagen in children and adults with GH deficiency.

Sartorio A, Arosio M, Conti A, Ferrero S, Porretti S, Faglia G. Sartorio A, et al. Among authors: ferrero s. J Endocrinol Invest. 1999 Mar;22(3):169-75. doi: 10.1007/BF03343537. J Endocrinol Invest. 1999. PMID: 10219883 Clinical Trial.

9

Mechanical and metabolic profile of locomotion in adults with childhood-onset GH deficiency.

Minetti AE, Ardigò LP, Saibene F, Ferrero S, Sartorio A. Minetti AE, et al. Among authors: ferrero s. Eur J Endocrinol. 2000 Jan;142(1):35-41. doi: 10.1530/eje.0.1420035. Eur J Endocrinol. 2000. PMID: 10633219

10

GH responsiveness to repeated GHRH or hexarelin administration in normal adults.

Sartorio A, Conti A, Ferrero S, Spada A, Faglia G. Sartorio A, et al. Among authors: ferrero s. J Endocrinol Invest. 1995 Oct;18(9):718-22. doi: 10.1007/BF03349794. J Endocrinol Invest. 1995. PMID: 8719303 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

972 results

Search Page

Filters